Showing 1 - 10 of 88
This paper studies the interaction between two dynamic domains, (1) an evolutionary biological system ('the environment') whose behaviour determines the availability of a resource stock, and (2) an industry where access to the resource stock is determined by the outcome of a patent race. The...
Persistent link: https://www.econbiz.de/10011597824
Persistent link: https://www.econbiz.de/10013407493
Persistent link: https://www.econbiz.de/10003357194
With the ongoing trade normalisation process between India and Pakistan, opportunities to integrate have opened up between both countries. The pharmaceutical sector is crucial to health issues in developing economies and would be an ideal segment to focus on in improving trade relations between...
Persistent link: https://www.econbiz.de/10010404687
Today, the global pharmaceutical product value chain is becoming increasingly complex and this has led to the emergence of 'multiple quality standards' for medicines. But this non-uniformity in the quality of medicine is also contingent upon both the regulatory milieu in the country of...
Persistent link: https://www.econbiz.de/10011337690
Persistent link: https://www.econbiz.de/10012817419
Persistent link: https://www.econbiz.de/10012803543
Persistent link: https://www.econbiz.de/10011765364
Persistent link: https://www.econbiz.de/10011765425
This paper considers those sectors of the economy that operate under the same regimes of rewarding private innovators as others, but differ in that they face recurring problems of resistance, as occur in the pharmaceutical and agricultural industries. This recurrence originates in the natural...
Persistent link: https://www.econbiz.de/10011591673